Chemodex

Nimbolide

CHF 232.00
In stock
CDX-N0360-M0055 mgCHF 232.00
More Information
Product Details
Synonyms NSC 309909
Product Type Chemical
Properties
Formula C27H30O7
MW 466.52
CAS 25990-37-8
RTECS GY2370000
Source/Host Chemicals Plant.
Purity Chemicals ≥98% (HPLC)
Appearance White to faint yellow powder.
Solubility Soluble in DMSO or DMF (10mg/ml).
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key JZIQWNPPBKFOPT-FTCZZEDLSA-N
Smiles CC1=C2[C@](CC1C3=COC=C3)([H])O[C@]([C@]2(C)[C@@H]4CC(OC)=O)([H])[C@@]5([H])C6[C@]4(C)C(C=C[C@@]6(C)C(O5)=O)=O
Shipping and Handling
Shipping AMBIENT
Short Term Storage -20°C
Long Term Storage -20°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

Nimbolide is a limonoid tetranortriterpenoid shown to exhibit anti-malarial, anti-bacterial, anti-inflammatory, anti-obesity and anti-cancer activities. Nimbolide induces cell cycle arrest, DNA damage and apoptosis, and modulates autophagy in cancer cell lines. It inhibits pancreatic cancer cell growth and metastasis by inducing the excessive generation of ROS, reducing PI3K/Akt/mTOR and ERK signaling, and upregulating the pro-apoptotic proteins Bax, caspase-3 and PARP. Nimbolide inhibits auto-ubiquitination of the E3 ligase RNF114 and p21 ubiquitination in vitro. This compound impairs proliferation of triple-negative breast cancer cell lines. Nimbolide also induces apoptotic cell death in a Waldenstroms macroglobulinemia cell line (BCWM1) and inhibits tumor growth in a xenograft model of Waldenstroms macroglobulinemia. Nimbolide can be used for the development of Degraders that utilize RNF114 as an E3 ligase for Targeted Protein Degradation. Nimbolide exerts protective effects in complete Freund's adjuvant induced inflammatory arthritis via abrogation of STAT-3/NF-?B/Notch-1 signaling. Nimbolide suppresses high fat diet (HFD) induced obesity via the Nrf2/HO-1 pathway.

Product References

[1] M.K. Roy, et al.; Phytother. Res. 21, 245 (2007) | [2] R.V. Priyadarsini, et al.; Free Radic. Res. 44, 624 (2010) | [3] S.C. Gupta, et al.; J. Biol. Chem. 286, 1134 (2011) | [4] S. Babykutty, et al.; Mol. Carcinogen. 51, 475 (2012) | [5] K. Chitta, et al; Blood Cancer J. 4, 260 (2014) | [6] L.N. Bodduluru, et al.; Toxicol. In Vitro 28, 1026 (2014) (Review) | [7] R. Subramani, et al.; Sci. Rep. 6, 19819 (2016) | [8] P. Sakar, et al.; J. Med. Microbiol. 65, 1205 (2016) | [9] J. Sophia, et al.; Cell Death Dis. 9, 1087 (2018) | [10] N. Mahmoud, et al.; Oncotarget 9, 35762 (2018) | [11] J.N. Spradin, et al.; Nat. Chem. Biol. 15, 747 (2019) | [12] B. Tong, et al.; ACS Chem. Biol. 15, 1788 (2020) | [13] P. Anchi, et al.; Life Sci. 266, 118911 (2021) | [14] S. Nagini, et al.; J. Med. Chem. 64, 3560 (2021) (Review) | [15] L. Zhang, et al.; J. Oleo Sci. 71, 709 (2022) | [16] P.K. Jaiswara & A. Kumar; Environ. Toxicol. 37, 1445 (2022)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.